Manish Bhandari

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study

Shaji Kumar, Ian W. Flinn, Stephen J. Noga et al. · Leukemia · 2010 · 81 citations

Medicine, Hematology, Oncology +16

Safety and Efficacy of Novel Combination Therapy with Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide in Newly Diagnosed Multiple Myeloma: Initial Results from the Phase I/II Multi-Center EVOLUTION Study

Shaji Kumar, Ian W. Flinn, Stephen J. Noga et al. · Blood · 2008 · 39 citations

Medicine, Hematology, Pharmacotherapy +17

Layout improvement of railway workshop using systematic layout planning (SLP) – A case study

Shubham Khariwal, Pradeep Kumar, Manish Bhandari · Materials Today Proceedings · 2020 · 22 citations

Management, Operations Management, Facilities Planning +9

Applications of Functionally Graded Materials (FGMs)

Neeraj Sharma, Manish Bhandari · 2018 · 18 citations

Natural Sciences, Materials Engineering, Materials Science +12